Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,644 | -8,174 | -34,345 | -15,485 | -9,684 |
| Depreciation Amortization | 2 | 1 | 333 | 332 | 51 |
| Other Working Capital | 784 | 1,144 | 1,969 | 617 | 166 |
| Other Operating Activity | 1,833 | 940 | 6,974 | 5,801 | 4,801 |
| Operating Cash Flow | $-13,025 | $-6,090 | $-25,069 | $-8,736 | $-4,667 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | -12 | -12 | -12 |
| Investing Cash Flow | $-3 | $N/A | $-12 | $-12 | $-12 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -1,219 | N/A | N/A |
| Common Stock Issued | 4,167 | N/A | 49,989 | 49,989 | 2,421 |
| Other Financing Activity | 730 | 181 | -1,284 | -2,517 | -944 |
| Financing Cash Flow | $4,897 | $181 | $47,485 | $47,471 | $1,476 |
| Beginning Cash Position | 36,975 | 36,975 | 14,571 | 14,571 | 14,571 |
| End Cash Position | 28,844 | 31,067 | 36,975 | 53,294 | 11,369 |
| Net Cash Flow | $-8,132 | $-5,909 | $22,404 | $38,723 | $-3,203 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,025 | -6,090 | -25,069 | -8,736 | -4,667 |
| Capital Expenditure | -3 | N/A | -12 | -12 | -12 |
| Free Cash Flow | -13,028 | -6,090 | -25,081 | -8,748 | -4,679 |